Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial enzymes of aerobic energy metabolism refer to the collective group of protein complexes that drive the respiratory electron transport chain and oxidative phosphorylation in bacteria (oup.com, portlandpress.com). This target entry encompasses multiple distinct enzymes, including NADH dehydrogenases (NDH-1 and NDH-2), succinate dehydrogenase, the cytochrome bcc complex, terminal oxidases, and the F1F0-ATP synthase (oup.com, asm.org). These components work in concert to generate a proton motive force across the bacterial membrane, which is then utilized to produce ATP, the primary energy currency for cellular processes (asm.org, walshmedicalmedia.com). In pathogens like Mycobacterium tuberculosis, these pathways are critical for survival during both active replication and dormant persistence, making them attractive targets for drug development (oup.com). The diarylquinoline bedaquiline, which inhibits ATP synthase, was the first drug in this class to receive FDA approval for multidrug-resistant tuberculosis (asm.org, nih.gov). Other candidates, such as telacebec (Q203), target the cytochrome bcc complex to disrupt respiration (portlandpress.com). A primary challenge in targeting these enzymes is achieving sufficient selectivity to avoid cross-reactivity with human mitochondrial respiratory complexes, thereby minimizing potential host toxicity (oup.com).
Inhibition of bacterial oxidative phosphorylation and ATP synthesis by blocking specific respiratory chain complexes or the ATP synthase enzyme, leading to energy depletion and loss of membrane potential.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial enzymes of aerobic energy metabolism.